Dissatisfaction with Pfizer’s Direct distribution deal remains significant, a major online survey of Pharmacy Guild members has revealed.
The Guild surveyed 911 community pharmacies during October, in response to reports of a range of problems, including medicine delays, after the program was introduced in February this year.
The surveyed pharmacists reported a total of 8194 patients had been ‘adversely impacted’ - defined as inferior access to Pfizer medicines compared to previous distribution by wholesalers - by the Pfizer model in the past month.
This represented an average of nine patients per pharmacy, with one reporting 79 patients had been affected.
On Pfizer’s performance since March, 21 per cent of respondents said it had improved, 59 per cent said it had...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.